U-Neuron Biomedical (ROCO:6973) Change In Payables And Accrued Expense : NT$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Change In Payables And Accrued Expense?

U-Neuron Biomedical's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was NT$0.00 Mil. It means U-Neuron Biomedical's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Dec. 2023 .

U-Neuron Biomedical's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was NT$0.00 Mil. It means U-Neuron Biomedical's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

U-Neuron Biomedical Change In Payables And Accrued Expense Historical Data

The historical data trend for U-Neuron Biomedical's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Change In Payables And Accrued Expense Chart

U-Neuron Biomedical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

U-Neuron Biomedical Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Payables And Accrued Expense	-	-	-	-	-

U-Neuron Biomedical Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

U-Neuron Biomedical Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

https://en.u-neuron.com

U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines